The vast majority of insurance companies require patients with Crohn's disease and ulcerative colitis to fail conventional treatment with steroids and immunomodulators before starting biologic therapy ...
Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — A presenter at the Crohn’s & Colitis Congress highlighted tips for successful decision-making with ...
Biologic therapies are generally safe for CKD patients, but conventional therapies and JAK inhibitors require caution due to potential renal impact. Corticosteroids should be used at the lowest ...
Inflammatory bowel disease (IBD) therapies for patients may need to be briefly halted during treatment for COVID-19, but it does not escalate IBD flares, with prior vaccination for COVID-19 helping ...
More than half a million patients in the UK have inflammatory bowel disease (IBD), and research suggests that up to 30% ...
How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback